Back to PathoKing

Alzheimer's module

Alzheimer's Disease

Trace amyloid, tau, synaptic failure, and network degeneration from episodic memory loss to progressive cognitive and functional dependence.

intermediate33 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Alzheimer's Disease?

Different triggers converge on the condition's central pathological process.

Age-related sporadic disease

Typical setting: Risk rises strongly with age through interacting protein-clearance, vascular, immune, and resilience changes.

Multifactorial biology permits amyloid and tau pathology to accumulate over years before symptoms.

APOE-associated susceptibility

Typical setting: APOE variants alter lipid transport, amyloid handling, and inflammatory response.

An e4 allele raises population risk but does not diagnose an individual or predict an inevitable outcome.

Autosomal dominant Alzheimer's disease

Typical setting: Rare APP, PSEN1, or PSEN2 variants cause younger-onset familial disease.

Altered amyloid processing produces highly penetrant pathology and requires specialist genetic counselling.

Down syndrome

Typical setting: An additional chromosome 21 increases APP gene dosage.

Amyloid pathology develops earlier, though cognitive diagnosis requires comparison with the person's own baseline.

Vascular and lifestyle contributors

Typical setting: Hypertension, diabetes, smoking, inactivity, hearing loss, and social isolation influence lifetime dementia risk.

They may reduce reserve, add vascular injury, or interact with neurodegenerative pathology.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

Amyloid-beta homeostasis becomes abnormal

Production, aggregation, and clearance become imbalanced, allowing extracellular deposits and toxic soluble species.

2

Tau becomes hyperphosphorylated and mislocalised

Microtubules destabilise and tau aggregates within neurons.

Checking account access...